Hot Features
プレミアム
Xenon Pharmaceuticals Inc (XENE)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-05 | Dr. Gary PatouIndependent Director | -1.32k | 70.25k | Automatic Disposition | 53.14 | 29.80k | -4.25% |
| 2026-06-05 | Dr. Gillian M. CannonIndependent Director | -1.19k | 63.24k | Automatic Disposition | 53.14 | 1.46k | -44.99% |
| 2026-06-01 | Mr. Justin D. GoverIndependent Director | 2.65k | 0.00 | Derivative Exercise and Retained Stock | - | 2.65k | - |
| 2026-06-01 | Dr. Gary PatouIndependent Director | 2.65k | 0.00 | Derivative Exercise and Retained Stock | - | 31.12k | 9.29% |
| 2026-06-01 | Mr. C. Patrick MachadoIndependent Director | 2.65k | 0.00 | Derivative Exercise and Retained Stock | - | 2.65k | - |
| 2026-06-01 | Dr. Elizabeth A. GarofaloIndependent Director | 2.65k | 0.00 | Derivative Exercise and Retained Stock | - | 2.65k | - |
| 2026-06-01 | Mr. Steven R. GannonIndependent Director | -1.42k | 75.63k | Derivative Exercise and Sale | 53.41 | 11.87k | - |
| 2026-06-01 | Mr. Steven R. GannonIndependent Director | 1.23k | 0.00 | Derivative Exercise and Retained Stock | - | 11.87k | 11.55% |
| 2026-06-01 | Dr. Gillian M. CannonIndependent Director | 2.65k | 0.00 | Derivative Exercise and Retained Stock | - | 2.65k | - |
| 2026-06-01 | Ms. Dawn A. SvoronosIndependent Chairman | -1.42k | 75.63k | Derivative Exercise and Sale | 53.41 | 26.23k | - |
| 2026-06-01 | Ms. Dawn A. SvoronosIndependent Chairman | 1.23k | 0.00 | Derivative Exercise and Retained Stock | - | 26.23k | 4.92% |
| 2026-05-12 | Mr. Steven R. GannonIndependent Director | 3.50k | 25.83k | Derivative Exercise and Retained Stock | 7.38 | 10.64k | 49.01% |
| 2026-03-12 | Ms. Andrea DiFabioChief Legal Officer & Corporate Secretary | 2.41k | 0.00 | Derivative Exercise and Retained Stock | - | 7.30k | 49.21% |
| 2026-03-12 | Ms. Andrea DiFabioChief Legal Officer & Corporate Secretary | -1.34k | 74.11k | Derivative Exercise and Sale | 55.23 | 7.30k | - |
| 2026-03-12 | Dr. Christopher John KenneyChief Medical Officer | 2.34k | 0.00 | Derivative Exercise and Retained Stock | - | 7.07k | 49.48% |
| 2026-03-12 | Dr. Christopher John KenneyChief Medical Officer | -1.41k | 77.87k | Derivative Exercise and Sale | 55.23 | 7.07k | - |
| 2026-03-12 | Mr. Ian C. MortimerPresident, CEO & Director | 5.19k | 0.00 | Derivative Exercise and Retained Stock | - | 34.22k | 17.88% |
| 2026-03-12 | Mr. Ian C. MortimerPresident, CEO & Director | -7.31k | 403.58k | Derivative Exercise and Sale | 55.23 | 34.22k | - |
| 2026-03-09 | Ms. Andrea DiFabioChief Legal Officer & Corporate Secretary | 4.89k | 0.00 | Derivative Exercise and Retained Stock | - | 4.89k | - |
| 2026-03-09 | Ms. Andrea DiFabioChief Legal Officer & Corporate Secretary | -2.61k | 156.70k | Derivative Exercise and Sale | 60.11 | 4.89k | - |
| 2026-03-09 | Dr. Christopher John KenneyChief Medical Officer | 4.73k | 0.00 | Derivative Exercise and Retained Stock | - | 4.73k | - |
| 2026-03-09 | Dr. Christopher John KenneyChief Medical Officer | -2.77k | 166.56k | Derivative Exercise and Sale | 60.11 | 4.73k | - |
| 2026-03-09 | Mr. Ian C. MortimerPresident, CEO & Director | 20.00k | 0.00 | Derivative Exercise and Retained Stock | - | 29.03k | 221.46% |
| 2026-03-09 | Mr. Ian C. MortimerPresident, CEO & Director | -270.00k | 14.47M | Derivative Exercise and Sale | 3.10 - 62.06 | 29.03k | - |
| 2026-03-10 | Mr. Ian C. MortimerPresident, CEO & Director | -11.27k | 677.36k | Automatic Disposition | 60.11 | 29.03k | -27.96% |
| 2026-01-02 | Mr. Ian C. MortimerPresident, CEO & Director | -40.00k | 1.48M | Derivative Exercise and Sale | 7.49 - 44.93 | 20.30k | - |
| 2025-12-05 | Mr. Ian C. MortimerPresident, CEO & Director | -25.21k | 1.14M | Automatic Disposition | 45.03 - 46.32 | 20.30k | -55.39% |
| 2025-11-28 | Mr. Ian C. MortimerPresident, CEO & Director | -97.00 | 4.37k | Automatic Disposition | 45.01 | 45.51k | -0.21% |
| 2025-10-15 | Mr. Thomas Patrick KellyCFO | 225.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | 29.87 | 225.00k | - |
| 2025-10-15 | Mr. Thomas Patrick KellyCFO | 30.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 30.00k | - |
| 2025-10-01 | Mr. Ian C. MortimerPresident, CEO & Director | -25.00k | 1.00M | 売り | 40.16 | 45.60k | -35.41% |
| 2025-10-01 | Mr. Ian C. MortimerPresident, CEO & Director | 25.00k | 192.25k | Derivative Exercise and Retained Stock | 7.69 | 45.60k | 121.35% |
| 2025-10-01 | Mr. Ian C. MortimerPresident, CEO & Director | -25.00k | 811.75k | Derivative Exercise and Sale | 7.69 - 40.16 | 45.60k | - |
| 2025-06-23 | Mr. Darren S. ClineChief Commercial Officer | 185.80k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | 22.93 | 185.80k | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
